🇺🇸 FDA
Patent

US 8802733

Aldehyde dehydrogenase inhibitors as novel depigmenting agents

granted A61KA61K31/145A61K31/16

Quick answer

US patent 8802733 (Aldehyde dehydrogenase inhibitors as novel depigmenting agents) held by The Board of Regents of the University of Texas System expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/145, A61K31/16, A61K31/26, A61K31/27